Acquisition opportunity: Agricultural chemicals company is looking to acquire an API business dealing in Atorvastatin. UDCA, Felbamate, etc.
Posted By - Investment Banker
Posted date - 25/05/2023
TARGET BRIEF
The target should be engaged in API business.
Preferable product portfolio including but not limited to -
- Atorvastatin,
- Rosuvastatin,
- UDCA,
- Felbamate,
- Artemether,
- Lumefantrine,
- Oncology APIs;
- APIs catering to various therapuetic segments.
Proposal
Industry
Pharmaceuticals
Sub Industry
API
Deal Size
INR 600 - 700 Cr
Funding Sources
Fresh Debt,Fresh Equity
Synergies Sought
Manufacturing Strengths (Production/Operations), Research & Development, Sales & Distribution, Financial, Access of resource in the industry
Deal Option
Complete Buyout
Open For Distressed Assets
Target Location
Pan India
Type
General
Product
Atorvastatin, Rosuvastatin, UDCA, Felbamate, Artemether, Lumefantrine, Oncology APIs;
Business Operation Information
Business Documents
Recommended Deals
A Pharmaceuticals (Contract Research & Manufacturing Services (CRAMS)) entity fr...
The Company is seeking acquisition targets in the CRO and/or CDMO space with the...